HRP20201880T1 - Transdermalni terapijski sustav namijenjen primjeni aktivne tvari - Google Patents
Transdermalni terapijski sustav namijenjen primjeni aktivne tvari Download PDFInfo
- Publication number
- HRP20201880T1 HRP20201880T1 HRP20201880TT HRP20201880T HRP20201880T1 HR P20201880 T1 HRP20201880 T1 HR P20201880T1 HR P20201880T T HRP20201880T T HR P20201880TT HR P20201880 T HRP20201880 T HR P20201880T HR P20201880 T1 HRP20201880 T1 HR P20201880T1
- Authority
- HR
- Croatia
- Prior art keywords
- active ingredient
- layer
- therapeutic system
- transdermal therapeutic
- polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10194968.3A EP2468274B1 (de) | 2010-12-14 | 2010-12-14 | Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs |
| PCT/EP2011/072812 WO2012080365A1 (de) | 2010-12-14 | 2011-12-14 | Transdermales therapeutisches system zur verabreichung eines wirkstoffs |
| EP11799413.7A EP2651410B1 (de) | 2010-12-14 | 2011-12-14 | Transdermales therapeutisches system zur verabreichung eines wirkstoffs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20201880T1 true HRP20201880T1 (hr) | 2021-02-05 |
Family
ID=43836835
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20201880TT HRP20201880T1 (hr) | 2010-12-14 | 2011-12-14 | Transdermalni terapijski sustav namijenjen primjeni aktivne tvari |
| HRP20150881TT HRP20150881T1 (hr) | 2010-12-14 | 2015-08-19 | Transdermalni terapijski sustav za primjenu sredstva |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20150881TT HRP20150881T1 (hr) | 2010-12-14 | 2015-08-19 | Transdermalni terapijski sustav za primjenu sredstva |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US10660863B2 (enExample) |
| EP (2) | EP2468274B1 (enExample) |
| JP (1) | JP6043296B2 (enExample) |
| KR (1) | KR101842309B1 (enExample) |
| CN (3) | CN103269698B (enExample) |
| AU (2) | AU2011343363B2 (enExample) |
| BR (1) | BR112013014616B1 (enExample) |
| CA (2) | CA3065240C (enExample) |
| CY (2) | CY1116638T1 (enExample) |
| DK (2) | DK2468274T3 (enExample) |
| EA (1) | EA026520B1 (enExample) |
| ES (2) | ES2545094T3 (enExample) |
| HK (1) | HK1243336A1 (enExample) |
| HR (2) | HRP20201880T1 (enExample) |
| HU (2) | HUE027916T2 (enExample) |
| LT (1) | LT2651410T (enExample) |
| MX (1) | MX345344B (enExample) |
| MY (1) | MY183873A (enExample) |
| PL (2) | PL2468274T3 (enExample) |
| PT (2) | PT2468274E (enExample) |
| RS (2) | RS54173B1 (enExample) |
| SI (2) | SI2468274T1 (enExample) |
| SM (2) | SMT202000638T1 (enExample) |
| WO (1) | WO2012080365A1 (enExample) |
| ZA (1) | ZA201303965B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102012000369A1 (de) * | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
| DE102012016317A1 (de) * | 2012-08-14 | 2014-02-20 | Jenabatteries GmbH | Redox-Flow-Zelle zur Speicherung elektrischer Energie |
| US20150196515A1 (en) * | 2012-08-15 | 2015-07-16 | Dow Coming Corporation | Multi-Layer Drug Delivery System |
| WO2014111790A2 (en) * | 2013-01-15 | 2014-07-24 | Zydus Technologies Limited | Stable transdermal pharmaceutical drug delivery system comprising rivastigmine |
| US20240082065A1 (en) * | 2016-07-08 | 2024-03-14 | Moteah Williams | Waterproof and transparent wound barrier and method of manufacturing same |
| EP3501518B1 (en) | 2016-08-22 | 2025-05-14 | Kyukyu Pharmaceutical Co., Ltd. | Transdermal patch of rivastigmine |
| JP7193863B2 (ja) * | 2017-07-19 | 2022-12-21 | 帝國製薬株式会社 | リバスチグミン含有経皮吸収型製剤 |
| DE102018120506A1 (de) * | 2017-10-20 | 2019-04-25 | Amw Gmbh | Stabilisiertes transdermales Darreichungssystem |
| DE102017127433A1 (de) * | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | TTS auf Basis von klebenden Weichmacher-Polymer-Matrices |
| CN111971032A (zh) * | 2018-03-13 | 2020-11-20 | 罗曼治疗系统股份公司 | 包含有机硅丙烯酸杂化聚合物的透皮治疗系统 |
| JP7170285B2 (ja) * | 2018-05-17 | 2022-11-14 | パナソニックＩｐマネジメント株式会社 | 生体貼付け用選択透過膜、経皮吸収キットおよび美容方法 |
| ES2923891T3 (es) | 2018-08-08 | 2022-10-03 | Danapak Flexibles As | Películas y láminas mejoradas para usarse en el envase de compuestos reactivos |
| KR102823139B1 (ko) | 2018-08-31 | 2025-06-19 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
| KR102710072B1 (ko) | 2018-08-31 | 2024-09-24 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
| EP3996693A1 (en) * | 2019-07-09 | 2022-05-18 | LTS Lohmann Therapie-Systeme AG | Transdermal therapeutic system comprising an active agent-containing layer comprising an acrylic polymer and a skin contact layer comprising a silicone gel adhesive |
| CN113616625B (zh) * | 2021-08-26 | 2023-05-30 | 大连科翔科技开发有限公司 | 一种卡巴拉汀的长效透皮贴剂 |
| DE102021128912A1 (de) * | 2021-11-05 | 2023-05-11 | Lts Lohmann Therapie-Systeme Ag. | Okklusives pflaster mit flexibler backing |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL195004C (nl) | 1987-03-04 | 2003-11-04 | Novartis Ag | Fenylcarbamaat bevattend farmaceutisch preparaat. |
| CA2142871A1 (en) * | 1992-08-25 | 1994-03-03 | Jesus Miranda | Printed transdermal drug delivery device |
| JPH0912448A (ja) * | 1995-04-28 | 1997-01-14 | Read Chem Kk | 薬物放出制御型経皮吸収製剤 |
| GB9800526D0 (en) | 1998-01-12 | 1998-03-11 | Ciba Geigy Ag | Organic compounds |
| US6348210B1 (en) * | 1998-11-13 | 2002-02-19 | Alza Corporation | Methods for transdermal drug administration |
| DE19918106A1 (de) | 1999-04-22 | 2000-10-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern |
| DE10033853A1 (de) | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| DE10103860B4 (de) * | 2001-01-30 | 2004-12-23 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung |
| DE10141650C1 (de) * | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
| DE10141652B4 (de) | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
| PL2216018T3 (pl) * | 2004-10-21 | 2012-09-28 | Durect Corp | Transdermalne systemy dostarczania |
| US8252319B2 (en) * | 2004-10-21 | 2012-08-28 | Durect Corporation | Transdermal delivery system for sufentanil |
| TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
| CN101351233A (zh) * | 2005-12-30 | 2009-01-21 | 科洛普拉斯特公司 | 具有可塑的层作为皮肤接触表面的层状粘合构造 |
| CN101304735A (zh) * | 2006-01-12 | 2008-11-12 | Lts勒曼治疗系统股份公司 | 用于挥发性和/或热不稳定的物质的经皮治疗体系 |
| CN101460156B (zh) * | 2006-05-08 | 2011-06-08 | 帝国制药株式会社 | 抗痴呆药的经皮吸收制剂 |
| US9248104B2 (en) | 2006-08-17 | 2016-02-02 | Core Tech Solutions, Inc. | Transdermal methods and systems for treating Alzheimer's disease |
| DE102006054731B4 (de) * | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
| EP2167001A4 (en) | 2007-07-10 | 2012-10-31 | Agile Therapeutics Inc | DEVICE FOR THE DERIVED ULTRASONIC WELDING |
| WO2009026135A2 (en) * | 2007-08-17 | 2009-02-26 | Alza Corporation | Controlled transdermal bisoprolol delivery system |
| WO2009107478A1 (ja) * | 2008-02-27 | 2009-09-03 | 久光製薬株式会社 | 貼付剤及び包装体 |
| US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
| JP2010126450A (ja) * | 2008-11-25 | 2010-06-10 | Lintec Corp | 経皮吸収貼付剤 |
| DK2515886T3 (en) * | 2009-12-22 | 2018-06-14 | Luye Pharma Ag | Transdermal therapeutic system for administration of rivastigmine or derivatives thereof |
-
2010
- 2010-12-14 EP EP10194968.3A patent/EP2468274B1/de active Active
- 2010-12-14 DK DK10194968.3T patent/DK2468274T3/en active
- 2010-12-14 PL PL10194968T patent/PL2468274T3/pl unknown
- 2010-12-14 HU HUE10194968A patent/HUE027916T2/en unknown
- 2010-12-14 SI SI201031006T patent/SI2468274T1/sl unknown
- 2010-12-14 ES ES10194968.3T patent/ES2545094T3/es active Active
- 2010-12-14 PT PT101949683T patent/PT2468274E/pt unknown
- 2010-12-14 RS RS20150562A patent/RS54173B1/sr unknown
-
2011
- 2011-12-14 MX MX2013005581A patent/MX345344B/es active IP Right Grant
- 2011-12-14 EA EA201300704A patent/EA026520B1/ru not_active IP Right Cessation
- 2011-12-14 LT LTEP11799413.7T patent/LT2651410T/lt unknown
- 2011-12-14 HU HUE11799413A patent/HUE052137T2/hu unknown
- 2011-12-14 HR HRP20201880TT patent/HRP20201880T1/hr unknown
- 2011-12-14 JP JP2013543774A patent/JP6043296B2/ja active Active
- 2011-12-14 CA CA3065240A patent/CA3065240C/en active Active
- 2011-12-14 WO PCT/EP2011/072812 patent/WO2012080365A1/de not_active Ceased
- 2011-12-14 US US13/994,242 patent/US10660863B2/en active Active
- 2011-12-14 DK DK11799413.7T patent/DK2651410T3/da active
- 2011-12-14 CN CN201180059614.1A patent/CN103269698B/zh active Active
- 2011-12-14 KR KR1020137016047A patent/KR101842309B1/ko active Active
- 2011-12-14 RS RS20201478A patent/RS61155B1/sr unknown
- 2011-12-14 CN CN202110438860.3A patent/CN113244199A/zh active Pending
- 2011-12-14 MY MYPI2013001975A patent/MY183873A/en unknown
- 2011-12-14 SM SM20200638T patent/SMT202000638T1/it unknown
- 2011-12-14 EP EP11799413.7A patent/EP2651410B1/de active Active
- 2011-12-14 CN CN201710451001.1A patent/CN107412202A/zh active Pending
- 2011-12-14 SI SI201131933T patent/SI2651410T1/sl unknown
- 2011-12-14 AU AU2011343363A patent/AU2011343363B2/en active Active
- 2011-12-14 ES ES11799413T patent/ES2836483T3/es active Active
- 2011-12-14 PL PL11799413T patent/PL2651410T3/pl unknown
- 2011-12-14 PT PT117994137T patent/PT2651410T/pt unknown
- 2011-12-14 BR BR112013014616-8A patent/BR112013014616B1/pt active IP Right Grant
- 2011-12-14 CA CA2817461A patent/CA2817461C/en active Active
-
2013
- 2013-05-30 ZA ZA2013/03965A patent/ZA201303965B/en unknown
-
2015
- 2015-07-31 SM SM201500184T patent/SMT201500184B/xx unknown
- 2015-08-19 HR HRP20150881TT patent/HRP20150881T1/hr unknown
- 2015-08-25 CY CY20151100738T patent/CY1116638T1/el unknown
-
2017
- 2017-08-11 AU AU2017213569A patent/AU2017213569B2/en active Active
-
2018
- 2018-02-28 HK HK18102858.7A patent/HK1243336A1/zh unknown
-
2020
- 2020-04-28 US US16/860,210 patent/US20200289426A1/en not_active Abandoned
- 2020-11-25 CY CY20201101121T patent/CY1123712T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20201880T1 (hr) | Transdermalni terapijski sustav namijenjen primjeni aktivne tvari | |
| JP6924298B2 (ja) | 経皮薬物送達組成物のためのシリコーン含有アクリルポリマー | |
| JP2014503523A5 (enExample) | ||
| WO2012084969A1 (en) | Adhesive composition containing rotigotine and transdermal therapeutic system comprising the adhesive composition | |
| US20160374956A1 (en) | Multilayer type patch | |
| ES2954087T3 (es) | Sistema de administración transdérmica que incluye un mediador de interfase | |
| KR20020062295A (ko) | 첩부제 | |
| CN102711744A (zh) | 用于施用利凡斯的明和其衍生物的透皮治疗系统 | |
| JP5665116B2 (ja) | 貼付剤および貼付製剤 | |
| CA2373171A1 (en) | Stretch plaster | |
| EP2599500A1 (en) | Adhesive patch for medical use | |
| KR102574287B1 (ko) | 아세나핀 함유 첩부제 | |
| WO2014111790A2 (en) | Stable transdermal pharmaceutical drug delivery system comprising rivastigmine | |
| KR102127531B1 (ko) | 부착 제제 | |
| US20150190349A1 (en) | Transdermal therapeutic system | |
| JP2022540442A (ja) | シリコーン含有ポリマーを含む活性剤含有層及びシリコーンゲル接着剤を含む皮膚接触層を含む経皮治療システム | |
| EP3764999A1 (en) | Transdermal therapeutic system containing nicotine and silicone acrylic hybrid polymer | |
| KR20120015423A (ko) | 접착 패치 및 패치 제제 | |
| CN103232819B (zh) | 粘贴制剂 | |
| CN110809466A (zh) | 含东莨菪碱和硅氧烷丙烯酸杂化聚合物的经皮治疗系统 | |
| JP2024099065A (ja) | 水性貼付剤 | |
| KR101688061B1 (ko) | 필로카르핀 경피 흡수 제제 | |
| CN118159255A (zh) | 具有柔性背衬的闭塞性贴剂 | |
| HK1187247B (en) | Transdermal therapeutic system for administering an active substance | |
| HK1187247A (en) | Transdermal therapeutic system for administering an active substance |